151 related articles for article (PubMed ID: 33880760)
41. Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses.
Wu G; Zheng Y; Zhou H; Hu X; Liu J; Zhai Y; Zhu M; Wu L; Shentu J
Drug Des Devel Ther; 2015; 9():5687-95. PubMed ID: 26527863
[TBL] [Abstract][Full Text] [Related]
42. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
[TBL] [Abstract][Full Text] [Related]
43. Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects.
Abbas R; Boni J; Sonnichsen D
Drug Metab Pers Ther; 2015 Mar; 30(1):57-63. PubMed ID: 25803093
[TBL] [Abstract][Full Text] [Related]
44. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
Martin PD; Warwick MJ; Dane AL; Brindley C; Short T
Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
[TBL] [Abstract][Full Text] [Related]
45. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
Nieminen TH; Hagelberg NM; Saari TI; Pertovaara A; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
Anesthesiology; 2009 Jun; 110(6):1371-8. PubMed ID: 19417618
[TBL] [Abstract][Full Text] [Related]
46. Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.
Chung JY; Cho JY; Yu KS; Kim JR; Oh DS; Jung HR; Lim KS; Moon KH; Shin SG; Jang IJ
Clin Pharmacol Ther; 2005 Oct; 78(4):342-50. PubMed ID: 16198653
[TBL] [Abstract][Full Text] [Related]
47. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers.
Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E
Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605
[TBL] [Abstract][Full Text] [Related]
48. CYP2C9*3(1075A>C), MDR1 G2677T/A and MDR1 C3435T are determinants of inter-subject variability in fluvastatin pharmacokinetics in healthy Chinese volunteers.
Zhou Q; Ruan ZR; Yuan H; Zeng S
Arzneimittelforschung; 2012 Nov; 62(11):519-24. PubMed ID: 22941809
[TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers.
Tse FL; Jaffe JM; Troendle A
J Clin Pharmacol; 1992 Jul; 32(7):630-8. PubMed ID: 1640002
[TBL] [Abstract][Full Text] [Related]
50. Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.
Watanabe M; Watanabe T; Yabuki M; Tamai I
Drug Metab Pharmacokinet; 2015 Apr; 30(2):198-204. PubMed ID: 25989893
[TBL] [Abstract][Full Text] [Related]
51. Unremarkable impact of Oatp inhibition on the liver concentration of fluvastatin, lovastatin and pitavastatin in wild-type and Oatp1a/1b knockout mouse.
Chang JH; Zhang X; Messick K; Chen YC; Chen E; Cheong J; Ly J
Xenobiotica; 2019 May; 49(5):602-610. PubMed ID: 29768081
[TBL] [Abstract][Full Text] [Related]
52. Effect of repeated administration of eslicarbazepine acetate on the pharmacokinetics of simvastatin in healthy subjects.
Falcão A; Pinto R; Nunes T; Soares-da-Silva P
Epilepsy Res; 2013 Sep; 106(1-2):244-9. PubMed ID: 23726291
[TBL] [Abstract][Full Text] [Related]
53. Effects of rifampicin on the pharmacokinetics and safety of carotegrast methyl in healthy subjects: A randomized 2 × 2 crossover study.
Imai H; Oikawa I; Koyama T; Matsuki S
Br J Clin Pharmacol; 2024 Jun; 90(6):1395-1407. PubMed ID: 38408756
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
Wenzler E; Ellis-Grosse EJ; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
[TBL] [Abstract][Full Text] [Related]
55. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
Deng S; Chen XP; Cao D; Yin T; Dai ZY; Luo J; Tang L; Li YJ
Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
[TBL] [Abstract][Full Text] [Related]
56. The pharmacokinetics of oral trazpiroben (TAK-906) after organic anion transporting polypeptide 1B1/1B3 inhibition: A phase I, randomized study.
Mukker JK; Dukes G; Tolkoff M; Wang L; Almansa C; Huh SY; Nishihara M; Ramsden D; Chen C
Clin Transl Sci; 2022 Jun; 15(6):1532-1543. PubMed ID: 35460165
[TBL] [Abstract][Full Text] [Related]
57. Single-dose Intravenous Safety, Tolerability, and Pharmacokinetics and Absolute Bioavailability of LCB01-0371.
Cho YS; Lim HS; Han S; Yoon SK; Kim H; Cho YL; Nam HS; Bae KS
Clin Ther; 2019 Jan; 41(1):92-106. PubMed ID: 30559004
[TBL] [Abstract][Full Text] [Related]
58. Differential changes in the pharmacokinetics of statins in collagen-induced arthritis rats.
Lin CH; Hsu KW; Chen CH; Uang YS; Lin CJ
Biochem Pharmacol; 2017 Oct; 142():216-228. PubMed ID: 28636885
[TBL] [Abstract][Full Text] [Related]
59. Effect of Rifampin on the Single-Dose Pharmacokinetics of Oral Cabotegravir in Healthy Subjects.
Ford SL; Sutton K; Lou Y; Zhang Z; Tenorio A; Trezza C; Patel P; Spreen W
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739783
[TBL] [Abstract][Full Text] [Related]
60. Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers.
Shah Y; Iqbal Z; Ahmad L; Khuda F; Khan A; Khan A; Khan MI; Ismail
Am J Ther; 2016; 23(6):e1514-e1523. PubMed ID: 25719441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
